Crossmark

712 Retrospective tumor microenvironment analysis from a personalized neoTCR-T cell therapy clinical trial and its potential applications for off-the-shelf HPV TCRs

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0712

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Stawiski, Eric

Smith, Chad

Borrman, Tyler

Pan, Zheng

Mandl, Stefanie

Bhardwaj, Vinnu
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03970382 at ClinicalTrials.gov

Documents that mention this clinical trial

34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019): part 1
https://doi.org/10.1186/s40425-019-0763-1

712 Retrospective tumor microenvironment analysis from a personalized neoTCR-T cell therapy clinical trial and its potential applications for off-the-shelf HPV TCRs
https://doi.org/10.1136/jitc-2022-sitc2022.0712

Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
https://doi.org/10.1136/jitc-2021-002723

820 Machine learning significantly improves neoantigen-HLA predictions utilizing > 26,000 data points from the PACTImmuneTM Database
https://doi.org/10.1136/jitc-2021-sitc2021.820

Document is current

Any future updates will be listed below